NeuroOne Medical Technologies Corporation Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
NeuroOne Medical Technologies Corporation (NMTC) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$226.83 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $361.41K, a 389.46% increase year-over-year.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $31.13K, a 4.35% decline year-over-year.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$619.38K.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $302.46K, a 27.73% increase year-over-year.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$54.44K, a 435.77% decline from fiscal 2024.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $16.21K.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$1.23M, a 185.40% decline from fiscal 2022.
- NeuroOne Medical Technologies Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $1.43M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $361.41K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2026-08-13 | $392.55K derived: sum of 2 quarters · filed 2026-08-13 | -$226.83K 10-Q · filed 2026-08-13 | $75.63K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $31.13K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2026-06-12 | -$588.24K 10-Q/A · filed 2026-06-12 | -$285.78K derived: sum of 3 quarters · filed 2026-06-12 | -$211.94K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$619.38K 10-Q · filed 2026-02-17 | -$316.91K derived: sum of 2 quarters · filed 2026-02-17 | -$243.07K derived: sum of 3 quarters · filed 2026-08-13 | -$210.53K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $302.46K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $376.30K derived: sum of 2 quarters · filed 2026-08-13 | $408.85K derived: sum of 3 quarters · filed 2026-08-13 | -$54.44K 10-K · filed 2025-12-17 |
| 2025-06-30 | $73.84K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2026-08-13 | $106.39K derived: sum of 2 quarters · filed 2026-08-13 | -$356.90K 10-Q · filed 2026-08-13 | -$120.11K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $32.55K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2026-06-12 | -$430.74K 10-Q/A · filed 2026-06-12 | -$193.95K derived: sum of 3 quarters · filed 2026-06-12 | $5.66K derived: sum of 4 quarters · filed 2026-06-12 |
| 2024-12-31 | -$463.29K 10-Q · filed 2026-02-17 | -$226.50K derived: sum of 2 quarters · filed 2026-02-17 | -$26.88K derived: sum of 3 quarters · filed 2026-02-17 | $71.51K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $236.79K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $436.41K derived: sum of 2 quarters · filed 2025-12-17 | $534.80K derived: sum of 3 quarters · filed 2025-12-17 | $16.21K 10-K · filed 2025-12-17 |
| 2024-06-30 | $199.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-14 | $298.00K derived: sum of 2 quarters · filed 2025-08-14 | -$220.58K 10-Q · filed 2025-08-14 | $64.21K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $98.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-13 | -$420.19K 10-Q · filed 2025-05-13 | -$135.40K derived: sum of 3 quarters · filed 2025-05-13 | $23.78K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$518.58K 10-Q · filed 2025-02-12 | -$233.79K derived: sum of 2 quarters · filed 2025-02-12 | -$74.61K derived: sum of 3 quarters · filed 2025-02-12 | -$1.44M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $284.79K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | $443.97K derived: sum of 2 quarters · filed 2024-12-17 | -$919.19K derived: sum of 3 quarters · filed 2024-12-17 | -$1.23M 10-K · filed 2024-12-17 |
| 2023-06-30 | $159.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | -$1.20M derived: sum of 2 quarters · filed 2024-08-14 | -$1.51M 10-Q · filed 2024-08-14 | $153.03K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-14 | -$1.67M 10-Q · filed 2024-05-14 | -$6.15K derived: sum of 3 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$306.13K 10-Q · filed 2024-02-13 | $1.36M derived: sum of 2 quarters · filed 2024-02-13 | ||
| 2022-09-30 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $1.43M 10-K · filed 2023-12-15 | ||
| 2022-06-30 | -$228.31K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |